Jinhe Biotechnology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.02%

Jinhe Biotechnology Co Ltd (002688) has an Asset Resilience Ratio of 0.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Jinhe Biotechnology Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.37 Million

≈ $200.01K USD Cash + Short-term Investments

Total Assets

CN¥5.58 Billion

≈ $817.26 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Jinhe Biotechnology Co Ltd's Asset Resilience Ratio has changed over time. See Jinhe Biotechnology Co Ltd book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jinhe Biotechnology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002688 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.37 Million	0.02%
Total Liquid Assets	CN¥1.37 Million	0.02%

Asset Resilience Insights

Limited Liquidity: Jinhe Biotechnology Co Ltd maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jinhe Biotechnology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jinhe Biotechnology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Jinhe Biotechnology Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Jinhe Biotechnology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.01%	CN¥553.12K ≈ $80.94K	CN¥5.65 Billion ≈ $826.86 Million	+0.00pp
2023-12-31	0.01%	CN¥507.66K ≈ $74.29K	CN¥5.45 Billion ≈ $798.06 Million	+0.16pp
2021-12-31	-0.15%	CN¥-6.24 Million ≈ $-912.65K	CN¥4.06 Billion ≈ $594.77 Million	+0.26pp
2020-12-31	-0.41%	CN¥-13.97 Million ≈ $-2.04 Million	CN¥3.38 Billion ≈ $494.14 Million	-0.10pp
2019-12-31	-0.31%	CN¥-10.34 Million ≈ $-1.51 Million	CN¥3.34 Billion ≈ $489.37 Million	-0.37pp
2018-12-31	0.06%	CN¥2.14 Million ≈ $313.21K	CN¥3.34 Billion ≈ $488.07 Million	+0.26pp
2016-12-31	-0.20%	CN¥-5.23 Million ≈ $-766.04K	CN¥2.66 Billion ≈ $389.58 Million	--

pp = percentage points

About Jinhe Biotechnology Co Ltd

SHE:002688 China Drug Manufacturers - Specialty & Generic

Market Cap

$679.74 Million

CN¥4.65 Billion CNY

Market Cap Rank

#10993 Global

#3257 in China

Share Price

CN¥6.02

Change (1 day)

+0.00%

52-Week Range

CN¥5.63 - CN¥7.91

All Time High

CN¥10.94